Irving JA - Search Results

1

A comprehensive analysis of the CDKN2A gene in childhood acute lymphoblastic leukemia reveals genomic deletion, copy number neutral loss of heterozygosity, and association with specific cytogenetic subgroups.

Sulong S, Moorman AV, Irving JA, Strefford JC, Konn ZJ, Case MC, Minto L, Barber KE, Parker H, Wright SL, Stewart AR, Bailey S, Bown NP, Hall AG, Harrison CJ. Sulong S, et al. Among authors: irving ja. Blood. 2009 Jan 1;113(1):100-7. doi: 10.1182/blood-2008-07-166801. Epub 2008 Oct 6. Blood. 2009. PMID: 18838613 Free article.

2

A case of mature B-cell ALL with coexistence of t(1;19) and t(14;18) and expression of the E2A/PBX1 fusion gene.

Rowe D, Devaraj PE, Irving JA, Hogarth L, Hall AG, Turner GE. Rowe D, et al. Among authors: irving ja. Br J Haematol. 1996 Jul;94(1):133-5. doi: 10.1046/j.1365-2141.1996.d01-1754.x. Br J Haematol. 1996. PMID: 8757523

3

New drugs, new drug resistance mechanisms.

Hall AG, Irving J. Hall AG, et al. Expert Rev Anticancer Ther. 2002 Jun;2(3):239-40. doi: 10.1586/14737140.2.3.239. Expert Rev Anticancer Ther. 2002. PMID: 12113037 No abstract available.

4

Mismatch repair defects as a cause of resistance to cytotoxic drugs.

Irving JA, Hall AG. Irving JA, et al. Expert Rev Anticancer Ther. 2001 Jun;1(1):149-58. doi: 10.1586/14737140.1.1.149. Expert Rev Anticancer Ther. 2001. PMID: 12113123 Review.

5

Molecular diagnostics: a healthcare perspective.

Hall AG, Coulthard SA, Irving JA. Hall AG, et al. Among authors: irving ja. Expert Rev Mol Diagn. 2003 Jan;3(1):13-6. doi: 10.1586/14737159.3.1.13. Expert Rev Mol Diagn. 2003. PMID: 12528360 Review.

6

Low prevalence of the N363S polymorphism of the glucocorticoid receptor in South Asians living in the United Kingdom.

Syed AA, Irving JA, Redfern CP, Hall AG, Unwin NC, White M, Bhopal RS, Alberti KG, Weaver JU. Syed AA, et al. Among authors: irving ja. J Clin Endocrinol Metab. 2004 Jan;89(1):232-5. doi: 10.1210/jc.2003-030995. J Clin Endocrinol Metab. 2004. PMID: 14715855

7

DNA mismatch repair pathway defects in the pathogenesis and evolution of myeloma.

Velangi MR, Matheson EC, Morgan GJ, Jackson GH, Taylor PR, Hall AG, Irving JA. Velangi MR, et al. Among authors: irving ja. Carcinogenesis. 2004 Oct;25(10):1795-803. doi: 10.1093/carcin/bgh187. Epub 2004 May 13. Carcinogenesis. 2004. PMID: 15142887

8

Use of denaturing HPLC for detection of mutations in the BCR-ABL kinase domain in patients resistant to Imatinib.

Irving JA, O'Brien S, Lennard AL, Minto L, Lin F, Hall AG. Irving JA, et al. Clin Chem. 2004 Jul;50(7):1233-7. doi: 10.1373/clinchem.2004.034801. Clin Chem. 2004. PMID: 15229152 No abstract available.

9

Loss of heterozygosity in childhood acute lymphoblastic leukemia detected by genome-wide microarray single nucleotide polymorphism analysis.

Irving JA, Bloodworth L, Bown NP, Case MC, Hogarth LA, Hall AG. Irving JA, et al. Cancer Res. 2005 Apr 15;65(8):3053-8. doi: 10.1158/0008-5472.CAN-04-2604. Cancer Res. 2005. PMID: 15833833

10

Detecting mismatch repair defects in myeloma.

Velangi M, Matheson E, Hall A, Irving J. Velangi M, et al. Methods Mol Med. 2005;113:269-77. doi: 10.1385/1-59259-916-8:269. Methods Mol Med. 2005. PMID: 15968110

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

218 results

Search Page

Filters